Hematology Analyzers and Reagents Market Share to Rise At 6.0% CAGR, To Hit USD 11.78 Billion by 2034 | PMR [Yahoo! Finance]
Danaher Corporation (DHR)
Last danaher corporation earnings: 1/30 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.danaher.com
Company Research
Source: Yahoo! Finance
New York, USA, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Market Details The global hematology analyzers and reagents market size is projected to grow from USD 6.57 billion in 2024 to USD 11.78 billion by 2034, at a CAGR of 6.0%, according to a new report by Polaris Market Research. Market Overview A hematology analyzer is one of the most broadly utilized instruments for clinical examination in hospitals. It can be segregated into human usage and veterinary usage as per the varied objects of usage. The hardware of both instruments is similar, but the contrast lies in the software. Thus, algorithms and citation ranges are varied. Hematology reagents are also necessary in the usage of hematology analyzers. The hematology reagents involve hemolytic agents, diluents, cleaning solutions, and intensive cleaning solutions. Download Free Sample PDF Copy of Report: https://www.polarismarketresearch.com/industry-analysis/hematology-analyzers-and-reagents-market/request-for-sample?utm_source=g
Show less
Read more
Impact Snapshot
Event Time:
DHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHR alerts
High impacting Danaher Corporation news events
Weekly update
A roundup of the hottest topics
DHR
News
- Danaher Co. (NYSE: DHR) is now covered by analysts at Guggenheim. They set a "buy" rating and a $275.00 price target on the stock.MarketBeat
- Australia Environmental Testing Market Report 2024-2031: Rising Adoption Among Government and R&D Laboratories Expected to Generate Growth Opportunities for Market Stakeholders [Yahoo! Finance]Yahoo! Finance
- James Webb Space Telescope best images of 2024 [USA TODAY]USA TODAY
- Medical Devices Technologies and Global Market Outlook 2024-2029, with Profiles of Abbott, BD, Danaher, Medtronic and F. Hoffmann-La Roche [Yahoo! Finance]Yahoo! Finance
- Danaher Co. (NYSE: DHR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
DHR
Earnings
- 10/22/24 - Beat
DHR
Sec Filings
- 12/19/24 - Form 4
- 12/11/24 - Form 8-K
- 11/27/24 - Form 4
- DHR's page on the SEC website